49
Views
0
CrossRef citations to date
0
Altmetric
Corrigendum

Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects [Corrigendum]

Page 61 | Published online: 27 Mar 2014

Figures & data

Figure 3 Mean anti-Xa activity and plasma apixaban concentration versus time following single-dose administration (day 1) and at steady state (day 9). Error bars show +1 standard deviation from the mean.

Figure 3 Mean anti-Xa activity and plasma apixaban concentration versus time following single-dose administration (day 1) and at steady state (day 9). Error bars show +1 standard deviation from the mean.